Moore
Moore v. GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 LISA M. MOORE, Case No. 20-cv-09077-JSW
Plaintiff,
REQUEST FOR CLARIFICATION RE
v. MOTION FOR APPROVAL OF CLASS
ACTION SETTLEMENT
GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC, et Re: Dkt. No. 129 al., Defendants. 12 13 The Court has received Plaintiff’s motion for approval of the Rule 23(b)(2) class action settlement, service award, and attorneys’ fees and costs. (Dkt. No. 129.) On January 30, 2024, the Court granted Plaintiff’s motion to certify a class under Rule 23(b)(2). (Dkt. 108.) The Court denied without prejudice the motion to certify a class under Rule 23(b)(3) on grounds that Dr. Michael Dennis’ consumer perception surveys and conjoint surveys did not sufficiently isolate the challenged language. (Id. at 10–11;17–18.) In so ruling, the Court specifically cited two decisions in this Circuit in which courts denied class certification on grounds that Dr. Dennis failed to isolate challenged language in…